FDA Inspection 1088553 — Sun Pharma Canada Inc.

Sun Pharma Canada Inc. — FEI 3002808384

The FDA completed an inspection of Sun Pharma Canada Inc. on May 3, 2019 in Brampton. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 3, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brampton (Canada)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
239721 CFR 211.194(a)(1)Description and Identification of Samples
457621 CFR 211.192No written record of investigation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.